FASN and breast carcinoma: Thus, inhibiting lipid metabolism using drugs such as statins, the inhibitor of carnitine palmitoyltransferase I (CPT1) etomoxir and the inhibitor of fatty acid synthase (FASN) TVB-2640 is emerging as a new strategy to counteract breast cancer chemoresistance [54–57].